316 related articles for article (PubMed ID: 15217496)
1. First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases.
Pérez-Alenza MD; Jiménez A; Nieto AI; Peña L
Breast Cancer Res; 2004; 6(4):R300-7. PubMed ID: 15217496
[TBL] [Abstract][Full Text] [Related]
2. A case of feline primary inflammatory mammary carcinoma: clinicopathological and immunohistochemical findings.
Millanta F; Verin R; Asproni P; Giannetti G; Poli A
J Feline Med Surg; 2012 Jun; 14(6):420-3. PubMed ID: 22408148
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
Millanta F; Caneschi V; Ressel L; Citi S; Poli A
J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
[TBL] [Abstract][Full Text] [Related]
4. Mammary invasive micropapillary carcinoma in cats: clinicopathologic features and nuclear DNA content.
Seixas F; Palmeira C; Pires MA; Lopes C
Vet Pathol; 2007 Nov; 44(6):842-8. PubMed ID: 18039897
[TBL] [Abstract][Full Text] [Related]
5. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
6. Metastasis of canine inflammatory versus non-inflammatory mammary tumours.
Clemente M; Pérez-Alenza MD; Peña L
J Comp Pathol; 2010; 143(2-3):157-63. PubMed ID: 20427049
[TBL] [Abstract][Full Text] [Related]
7. Complex carcinomas of the mammary gland in cats: pathological and immunohistochemical features.
Seixas F; Pires MA; Lopes CA
Vet J; 2008 May; 176(2):210-5. PubMed ID: 17459738
[TBL] [Abstract][Full Text] [Related]
8. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
9. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
11. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
12. Are complex carcinoma of the feline mammary gland and other invasive mammary carcinoma identical tumours? Comparison of clinicopathologic features, DNA ploidy and follow up.
Seixas F; Palmeira C; Pires MA; Lopes C
Res Vet Sci; 2008 Jun; 84(3):428-33. PubMed ID: 17663997
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
[TBL] [Abstract][Full Text] [Related]
14. Mammary adenocarcinomas in three male cats exposed to medroxyprogesterone acetate (1990-2006).
Jacobs TM; Hoppe BR; Poehlmann CE; Ferracone JD; Sorenmo KU
J Feline Med Surg; 2010 Feb; 12(2):169-74. PubMed ID: 19818661
[TBL] [Abstract][Full Text] [Related]
15. Comparative value of clinical, cytological, and histopathological features in feline mammary gland tumors; an experimental model for the study of human breast cancer.
Shafiee R; Javanbakht J; Atyabi N; Bahrami A; Kheradmand D; Safaei R; Khadivar F; Hosseini E
Diagn Pathol; 2013 Aug; 8():136. PubMed ID: 23941603
[TBL] [Abstract][Full Text] [Related]
16. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
Clemente M; Pérez-Alenza MD; Illera JC; Peña L
Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of a canine xenograft model of inflammatory mammary carcinoma.
Camacho L; Peña L; González Gil A; Cáceres S; Díez L; Illera JC
Res Vet Sci; 2013 Dec; 95(3):1068-75. PubMed ID: 23972378
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of STAT3-p-tyr705 expression in feline mammary gland tumours and correlation with histologic grade.
Petterino C; Ratto A; Podestà G; Drigo M; Pellegrino C
Res Vet Sci; 2007 Apr; 82(2):218-24. PubMed ID: 16934302
[TBL] [Abstract][Full Text] [Related]
19. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
[TBL] [Abstract][Full Text] [Related]
20. Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance.
Queiroga FL; Perez-Alenza MD; Silvan G; Peña L; Lopes C; Illera JC
Anticancer Res; 2005; 25(6B):4269-75. PubMed ID: 16309227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
